data_2gcc_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2gcc _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.489 0.661 . . . . 0.0 109.63 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.58 117.18 34.19 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.538 -0.727 . . . . 0.0 109.61 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.684 ' CD2' ' HB3' ' A' ' 183' ' ' ALA . 11.2 m-85 -85.25 137.26 33.1 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.328 -0.857 . . . . 0.0 109.167 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -70.94 104.01 2.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.226 -0.921 . . . . 0.0 109.402 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 116.16 -20.0 13.04 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 18.3 t -98.08 122.07 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.045 -1.268 . . . . 0.0 110.097 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.7 mtt180 -101.49 129.13 47.49 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLN . . . . . 0.42 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 8.5 pt20 -99.95 147.24 25.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 110.432 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -112.19 159.28 34.39 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.553 -0.717 . . . . 0.0 109.339 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -81.05 35.16 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.726 2.284 . . . . 0.0 110.424 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -140.23 -33.63 0.56 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.054 -1.029 . . . . 0.0 110.237 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 133.97 19.65 0.89 Allowed Glycine 0 N--CA 1.496 2.692 0 C-N-CA 119.736 -1.221 . . . . 0.0 110.751 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -120.52 159.8 24.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.911 -1.346 . . . . 0.0 109.187 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PHE . . . . . 0.531 ' CE2' ' HB1' ' A' ' 179' ' ' ALA . 67.0 m-85 -135.15 -179.92 5.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.175 -0.953 . . . . 0.0 109.009 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ALA . . . . . 0.601 ' HB3' ' CZ2' ' A' ' 172' ' ' TRP . . . -152.48 119.45 5.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.158 -0.964 . . . . 0.0 110.208 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.421 ' HB1' ' CE1' ' A' ' 176' ' ' PHE . . . -92.0 123.43 35.36 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' GLU . . . . . 0.417 ' HG3' ' C ' ' A' ' 159' ' ' ALA . 21.7 mt-10 -142.21 149.54 39.79 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ILE . . . . . 0.451 ' CG2' ' HB ' ' A' ' 171' ' ' VAL . 12.2 tt -129.54 151.88 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.022 -1.049 . . . . 0.0 109.837 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -97.52 118.16 33.41 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -111.48 110.52 55.48 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.701 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.32 -29.23 2.57 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.449 2.099 . . . . 0.0 110.23 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.34 -22.25 66.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.478 -0.764 . . . . 0.0 110.418 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -93.78 38.63 1.07 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.983 -1.073 . . . . 0.0 109.884 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.36 31.0 15.46 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.214 -0.929 . . . . 0.0 110.156 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.6 68.38 1.63 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -125.08 153.41 42.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -1.159 . . . . 0.0 109.017 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -88.3 159.29 18.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.103 -0.998 . . . . 0.0 110.356 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . 0.451 ' HB ' ' CG2' ' A' ' 161' ' ' ILE . 21.7 t -135.24 83.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' TRP . . . . . 0.601 ' CZ2' ' HB3' ' A' ' 158' ' ' ALA . 4.5 t-105 -74.01 103.51 4.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.37 -0.831 . . . . 0.0 109.662 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' LEU . . . . . 0.419 ' HB2' ' HB2' ' A' ' 159' ' ' ALA . 1.4 mt -63.01 -46.88 85.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.378 -0.826 . . . . 0.0 109.642 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 150.36 159.38 8.71 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.503 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.2 OUTLIER -77.37 155.57 31.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.266 -1.138 . . . . 0.0 109.015 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' PHE . . . . . 0.55 ' CD1' ' HA ' ' A' ' 182' ' ' ALA . 72.2 m-85 -128.9 -176.08 3.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.348 -0.845 . . . . 0.0 109.735 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -92.33 -29.12 16.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.395 -0.815 . . . . 0.0 110.086 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' THR . . . . . 0.439 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 16.7 p -139.77 172.85 12.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.019 . . . . 0.0 109.492 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.531 ' HB1' ' CE2' ' A' ' 157' ' ' PHE . . . -74.55 -20.46 59.94 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.316 -0.865 . . . . 0.0 109.497 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -75.88 -42.48 49.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 110.151 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.16 -46.0 65.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.256 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.55 ' HA ' ' CD1' ' A' ' 176' ' ' PHE . . . -67.62 -24.77 65.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.315 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ALA . . . . . 0.684 ' HB3' ' CD2' ' A' ' 146' ' ' TYR . . . -79.85 -34.02 39.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.794 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . . . . . . . . . 19.9 tp -73.98 -35.97 64.52 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ALA . . . . . 0.409 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.95 -30.8 71.02 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' TYR . . . . . 0.426 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 22.3 t80 -67.86 -35.08 77.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.463 -0.773 . . . . 0.0 109.614 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . 0.431 ' OD2' ' HB2' ' A' ' 202' ' ' PHE . 6.0 m-20 -64.82 -41.53 95.69 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.293 -0.88 . . . . 0.0 110.374 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.3 -35.41 80.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.26 -0.9 . . . . 0.0 110.644 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ALA . . . . . . . . . . . . . . . -81.3 -24.17 37.39 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.044 -1.035 . . . . 0.0 109.774 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.524 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.02 -3.81 58.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.944 . . . . 0.0 109.704 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -104.9 -30.78 9.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.072 -1.017 . . . . 0.0 109.039 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -80.24 -38.21 31.46 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.88 -35.57 57.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.779 -0.576 . . . . 0.0 110.585 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ARG . . . . . 0.524 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 7.3 mtt-85 -90.28 -20.74 22.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.084 -1.01 . . . . 0.0 109.395 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 81.6 -124.23 6.37 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 120.14 -1.029 . . . . 0.0 112.034 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' SER . . . . . 0.516 ' O ' ' O ' ' A' ' 197' ' ' ARG . 72.6 m -71.21 125.23 26.37 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.667 -0.902 . . . . 0.0 112.011 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ARG . . . . . 0.516 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 55.14 141.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.893 0.854 . . . . 0.0 110.824 178.104 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ALA . . . . . . . . . . . . . . . -169.21 155.6 6.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.237 -0.914 . . . . 0.0 108.793 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.05 108.01 19.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.123 -0.986 . . . . 0.0 109.49 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -116.55 166.78 11.71 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.257 -0.902 . . . . 0.0 109.789 -179.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -38.22 90.3 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.565 ' CZ ' ' HB2' ' A' ' 183' ' ' ALA . 6.1 m-85 -115.54 93.03 35.31 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -70.57 85.52 0.73 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.276 1.984 . . . . 0.0 110.042 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -44.4 132.54 5.97 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.243 0.544 . . . . 0.0 110.51 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' ARG . . . . . 0.547 ' NE ' ' HA ' ' A' ' 205' ' ' ARG . 1.9 tpm_? -172.44 44.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.457 -0.777 . . . . 0.0 109.486 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' VAL . . . . . 0.433 ' CG2' ' O ' ' A' ' 205' ' ' ARG . 22.0 t . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.205 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.489 0.661 . . . . 0.0 109.63 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.58 117.18 34.19 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.538 -0.727 . . . . 0.0 109.61 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.721 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 11.2 m-85 -85.25 137.26 33.1 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.328 -0.857 . . . . 0.0 109.167 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -70.94 104.01 2.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.226 -0.921 . . . . 0.0 109.402 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 116.16 -20.0 13.04 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 18.3 t -98.08 122.07 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.045 -1.268 . . . . 0.0 110.097 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.7 mtt180 -101.49 129.13 47.49 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLN . . . . . 0.437 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 8.5 pt20 -99.95 147.24 25.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 110.432 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -112.19 159.28 34.39 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.553 -0.717 . . . . 0.0 109.339 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -81.05 35.16 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.726 2.284 . . . . 0.0 110.424 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -140.23 -33.63 0.56 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.054 -1.029 . . . . 0.0 110.237 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 133.97 19.65 0.89 Allowed Glycine 0 N--CA 1.496 2.692 0 C-N-CA 119.736 -1.221 . . . . 0.0 110.751 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -120.52 159.8 24.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.911 -1.346 . . . . 0.0 109.187 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PHE . . . . . 0.708 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 67.0 m-85 -135.15 -179.92 5.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.175 -0.953 . . . . 0.0 109.009 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -152.48 119.45 5.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.158 -0.964 . . . . 0.0 110.208 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.427 ' C ' ' HG3' ' A' ' 160' ' ' GLU . . . -92.0 123.43 35.36 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' GLU . . . . . 0.427 ' HG3' ' C ' ' A' ' 159' ' ' ALA . 21.7 mt-10 -142.21 149.54 39.79 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ILE . . . . . 0.518 HG23 ' HB ' ' A' ' 171' ' ' VAL . 12.2 tt -129.54 151.88 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.022 -1.049 . . . . 0.0 109.837 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -97.52 118.16 33.41 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -111.48 110.52 55.48 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.701 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.32 -29.23 2.57 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.449 2.099 . . . . 0.0 110.23 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.34 -22.25 66.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.478 -0.764 . . . . 0.0 110.418 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -93.78 38.63 1.07 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.983 -1.073 . . . . 0.0 109.884 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.36 31.0 15.46 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.214 -0.929 . . . . 0.0 110.156 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.6 68.38 1.63 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -125.08 153.41 42.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -1.159 . . . . 0.0 109.017 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -88.3 159.29 18.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.103 -0.998 . . . . 0.0 110.356 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' VAL . . . . . 0.615 ' O ' HG12 ' A' ' 171' ' ' VAL . 21.7 t -135.24 83.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' TRP . . . . . 0.521 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 4.5 t-105 -74.01 103.51 4.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.37 -0.831 . . . . 0.0 109.662 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' LEU . . . . . 0.861 HD21 ' HB2' ' A' ' 189' ' ' ALA . 1.4 mt -63.01 -46.88 85.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.378 -0.826 . . . . 0.0 109.642 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 150.36 159.38 8.71 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.2 OUTLIER -77.37 155.57 31.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.266 -1.138 . . . . 0.0 109.015 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 176' ' ' PHE . . . . . 0.794 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 72.2 m-85 -128.9 -176.08 3.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.348 -0.845 . . . . 0.0 109.735 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -92.33 -29.12 16.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.395 -0.815 . . . . 0.0 110.086 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' THR . . . . . 0.445 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 16.7 p -139.77 172.85 12.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.019 . . . . 0.0 109.492 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.708 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -74.55 -20.46 59.94 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.316 -0.865 . . . . 0.0 109.497 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -75.88 -42.48 49.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 110.151 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.16 -46.0 65.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.256 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.794 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -67.62 -24.77 65.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.315 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ALA . . . . . 0.721 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -79.85 -34.02 39.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.794 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 184' ' ' LEU . 19.9 tp -73.98 -35.97 64.52 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ALA . . . . . 0.409 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.95 -30.8 71.02 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' TYR . . . . . 0.426 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 22.3 t80 -67.86 -35.08 77.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.463 -0.773 . . . . 0.0 109.614 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ASP . . . . . 0.426 ' OD2' ' HB2' ' A' ' 202' ' ' PHE . 6.0 m-20 -64.82 -41.53 95.69 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.293 -0.88 . . . . 0.0 110.374 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.3 -35.41 80.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.26 -0.9 . . . . 0.0 110.644 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ALA . . . . . 0.861 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -81.3 -24.17 37.39 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.044 -1.035 . . . . 0.0 109.774 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.02 -3.81 58.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.944 . . . . 0.0 109.704 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -104.9 -30.78 9.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.072 -1.017 . . . . 0.0 109.039 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -80.24 -38.21 31.46 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.88 -35.57 57.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.779 -0.576 . . . . 0.0 110.585 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 7.3 mtt-85 -90.28 -20.74 22.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.084 -1.01 . . . . 0.0 109.395 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 81.6 -124.23 6.37 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 120.14 -1.029 . . . . 0.0 112.034 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' SER . . . . . 0.516 ' O ' ' O ' ' A' ' 197' ' ' ARG . 72.6 m -71.21 125.23 26.37 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.667 -0.902 . . . . 0.0 112.011 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ARG . . . . . 0.516 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 55.14 141.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.893 0.854 . . . . 0.0 110.824 178.104 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ALA . . . . . 0.508 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -169.21 155.6 6.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.237 -0.914 . . . . 0.0 108.793 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.05 108.01 19.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.123 -0.986 . . . . 0.0 109.49 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . 0.508 HD21 ' HB3' ' A' ' 198' ' ' ALA . 0.1 OUTLIER -116.55 166.78 11.71 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.257 -0.902 . . . . 0.0 109.789 -179.662 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -38.22 90.3 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.426 ' HB2' ' OD2' ' A' ' 187' ' ' ASP . 6.1 m-85 -115.54 93.03 35.31 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -70.57 85.52 0.73 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.276 1.984 . . . . 0.0 110.042 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -44.4 132.54 5.97 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.243 0.544 . . . . 0.0 110.51 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' ARG . . . . . 0.56 ' NE ' ' HA ' ' A' ' 205' ' ' ARG . 1.9 tpm_? -172.44 44.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.457 -0.777 . . . . 0.0 109.486 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' VAL . . . . . 0.452 HG23 ' C ' ' A' ' 205' ' ' ARG . 22.0 t . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.205 179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.489 0.661 . . . . 0.0 109.63 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -100.58 117.18 34.19 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.538 -0.727 . . . . 0.0 109.61 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.721 ' CD2' ' HB2' ' A' ' 183' ' ' ALA . 11.2 m-85 -85.25 137.26 33.1 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.328 -0.857 . . . . 0.0 109.167 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 82.4 mtt180 -70.94 104.01 2.83 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.226 -0.921 . . . . 0.0 109.402 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' GLY . . . . . . . . . . . . . . . 116.16 -20.0 13.04 Favored Glycine 0 N--CA 1.488 2.16 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' VAL . . . . . 0.531 ' HB ' ' HB2' ' A' ' 146' ' ' TYR . 18.3 t -98.08 122.07 49.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.045 -1.268 . . . . 0.0 110.097 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' ARG . . . . . . . . . . . . . 37.7 mtt180 -101.49 129.13 47.49 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 178.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLN . . . . . 0.437 ' HB3' ' CE2' ' A' ' 157' ' ' PHE . 8.5 pt20 -99.95 147.24 25.78 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.284 -0.885 . . . . 0.0 110.432 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 47.1 mtt180 -112.19 159.28 34.39 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.553 -0.717 . . . . 0.0 109.339 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -81.05 35.16 0.57 Allowed 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.726 2.284 . . . . 0.0 110.424 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' TRP . . . . . . . . . . . . . 8.6 t-105 -140.23 -33.63 0.56 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.054 -1.029 . . . . 0.0 110.237 -179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 133.97 19.65 0.89 Allowed Glycine 0 N--CA 1.496 2.692 0 C-N-CA 119.736 -1.221 . . . . 0.0 110.751 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LYS . . . . . . . . . . . . . 70.3 mttt -120.52 159.8 24.46 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 120.911 -1.346 . . . . 0.0 109.187 179.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PHE . . . . . 0.708 ' CE2' ' HB2' ' A' ' 179' ' ' ALA . 67.0 m-85 -135.15 -179.92 5.92 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.175 -0.953 . . . . 0.0 109.009 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ALA . . . . . 0.538 ' HA ' ' HA ' ' A' ' 175' ' ' THR . . . -152.48 119.45 5.81 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.158 -0.964 . . . . 0.0 110.208 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.427 ' C ' ' HG3' ' A' ' 160' ' ' GLU . . . -92.0 123.43 35.36 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' GLU . . . . . 0.427 ' HG3' ' C ' ' A' ' 159' ' ' ALA . 21.7 mt-10 -142.21 149.54 39.79 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 -179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ILE . . . . . 0.518 HG23 ' HB ' ' A' ' 171' ' ' VAL . 12.2 tt -129.54 151.88 36.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.022 -1.049 . . . . 0.0 109.837 179.711 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -97.52 118.16 33.41 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 41.4 t0 -111.48 110.52 55.48 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.221 -0.924 . . . . 0.0 109.701 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -80.32 -29.23 2.57 Favored 'Trans proline' 0 C--N 1.312 -1.353 0 C-N-CA 122.449 2.099 . . . . 0.0 110.23 179.774 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ALA . . . . . . . . . . . . . . . -63.34 -22.25 66.76 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.478 -0.764 . . . . 0.0 110.418 -179.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 62.2 mmtt -93.78 38.63 1.07 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.983 -1.073 . . . . 0.0 109.884 -179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 63.36 31.0 15.46 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.214 -0.929 . . . . 0.0 110.156 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 71.6 68.38 1.63 Allowed Glycine 0 N--CA 1.493 2.449 0 N-CA-C 110.091 -1.203 . . . . 0.0 110.091 179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ALA . . . . . . . . . . . . . . . -125.08 153.41 42.97 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.23 -1.159 . . . . 0.0 109.017 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ARG . . . . . . . . . . . . . 52.5 mtt180 -88.3 159.29 18.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.103 -0.998 . . . . 0.0 110.356 -179.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . 0.615 ' O ' HG12 ' A' ' 171' ' ' VAL . 21.7 t -135.24 83.37 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 179.046 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' TRP . . . . . 0.521 ' CZ2' ' HB1' ' A' ' 158' ' ' ALA . 4.5 t-105 -74.01 103.51 4.52 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.37 -0.831 . . . . 0.0 109.662 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' LEU . . . . . 0.861 HD21 ' HB2' ' A' ' 189' ' ' ALA . 1.4 mt -63.01 -46.88 85.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.378 -0.826 . . . . 0.0 109.642 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 150.36 159.38 8.71 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.772 -1.331 . . . . 0.0 109.772 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 158' ' ' ALA . 0.2 OUTLIER -77.37 155.57 31.82 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.266 -1.138 . . . . 0.0 109.015 179.652 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' PHE . . . . . 0.794 ' HB2' ' HB2' ' A' ' 182' ' ' ALA . 72.2 m-85 -128.9 -176.08 3.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.348 -0.845 . . . . 0.0 109.735 -179.639 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -92.33 -29.12 16.52 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.395 -0.815 . . . . 0.0 110.086 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' THR . . . . . 0.445 ' HA ' ' CE1' ' A' ' 157' ' ' PHE . 16.7 p -139.77 172.85 12.19 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.069 -1.019 . . . . 0.0 109.492 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.708 ' HB2' ' CE2' ' A' ' 157' ' ' PHE . . . -74.55 -20.46 59.94 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.316 -0.865 . . . . 0.0 109.497 179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLU . . . . . . . . . . . . . 52.2 tt0 -75.88 -42.48 49.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.241 -0.912 . . . . 0.0 110.151 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -70.16 -46.0 65.57 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.241 -0.912 . . . . 0.0 109.256 -179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.794 ' HB2' ' HB2' ' A' ' 176' ' ' PHE . . . -67.62 -24.77 65.51 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 109.315 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ALA . . . . . 0.721 ' HB2' ' CD2' ' A' ' 146' ' ' TYR . . . -79.85 -34.02 39.68 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.299 -0.876 . . . . 0.0 109.794 -179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.448 ' HA ' HD12 ' A' ' 184' ' ' LEU . 19.9 tp -73.98 -35.97 64.52 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.748 -0.834 . . . . 0.0 108.748 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ALA . . . . . 0.409 ' CB ' ' CZ ' ' A' ' 176' ' ' PHE . . . -66.95 -30.8 71.02 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' TYR . . . . . 0.426 ' CD1' ' C ' ' A' ' 186' ' ' TYR . 22.3 t80 -67.86 -35.08 77.92 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.463 -0.773 . . . . 0.0 109.614 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . 0.426 ' OD2' ' HB2' ' A' ' 202' ' ' PHE . 6.0 m-20 -64.82 -41.53 95.69 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.293 -0.88 . . . . 0.0 110.374 -179.482 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.3 -35.41 80.91 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.26 -0.9 . . . . 0.0 110.644 -179.056 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ALA . . . . . 0.861 ' HB2' HD21 ' A' ' 173' ' ' LEU . . . -81.3 -24.17 37.39 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.044 -1.035 . . . . 0.0 109.774 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.536 ' O ' ' HB2' ' A' ' 194' ' ' ARG . . . -88.02 -3.81 58.86 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.19 -0.944 . . . . 0.0 109.704 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' PHE . . . . . . . . . . . . . 2.8 t80 -104.9 -30.78 9.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.072 -1.017 . . . . 0.0 109.039 179.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ARG . . . . . . . . . . . . . 9.3 ttm180 -80.24 -38.21 31.46 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 108.372 -0.974 . . . . 0.0 108.372 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -76.88 -35.57 57.33 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.779 -0.576 . . . . 0.0 110.585 -179.592 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 190' ' ' ALA . 7.3 mtt-85 -90.28 -20.74 22.59 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.084 -1.01 . . . . 0.0 109.395 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLY . . . . . . . . . . . . . . . 81.6 -124.23 6.37 Favored Glycine 0 N--CA 1.494 2.526 0 C-N-CA 120.14 -1.029 . . . . 0.0 112.034 177.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' SER . . . . . 0.516 ' O ' ' O ' ' A' ' 197' ' ' ARG . 72.6 m -71.21 125.23 26.37 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.667 -0.902 . . . . 0.0 112.011 -177.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ARG . . . . . 0.516 ' O ' ' O ' ' A' ' 196' ' ' SER . 0.0 OUTLIER 55.14 141.32 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 121.893 0.854 . . . . 0.0 110.824 178.104 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ALA . . . . . 0.508 ' HB3' HD21 ' A' ' 200' ' ' LEU . . . -169.21 155.6 6.56 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.237 -0.914 . . . . 0.0 108.793 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.05 108.01 19.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.123 -0.986 . . . . 0.0 109.49 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . 0.508 HD21 ' HB3' ' A' ' 198' ' ' ALA . 0.1 OUTLIER -116.55 166.78 11.71 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.257 -0.902 . . . . 0.0 109.789 -179.662 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -38.22 90.3 Favored 'General case' 0 N--CA 1.494 1.765 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 178.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.426 ' HB2' ' OD2' ' A' ' 187' ' ' ASP . 6.1 m-85 -115.54 93.03 35.31 Favored Pre-proline 0 C--N 1.305 -1.358 0 N-CA-C 107.469 -1.308 . . . . 0.0 107.469 178.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' PRO . . . . . . . . . . . . . 28.8 Cg_endo -70.57 85.52 0.73 Allowed 'Trans proline' 0 C--N 1.311 -1.397 0 C-N-CA 122.276 1.984 . . . . 0.0 110.042 -179.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -44.4 132.54 5.97 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.243 0.544 . . . . 0.0 110.51 -179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' ARG . . . . . 0.56 ' NE ' ' HA ' ' A' ' 205' ' ' ARG . 1.9 tpm_? -172.44 44.1 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.457 -0.777 . . . . 0.0 109.486 178.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' VAL . . . . . 0.452 HG23 ' C ' ' A' ' 205' ' ' ARG . 22.0 t . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 118.028 -0.987 . . . . 0.0 109.205 179.732 . . . . . . . . 1 1 . 1 stop_ save_